Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.59 |
| ▸ | IGF1R | P08069 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.56 |
| ▸ | TACR2 | P21452 | 2/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SHBG | P04278 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11666919 | 1.00 | KAT8 (0.59) | KAT8IGF1RALOX15PTGS2ESR1 | |
| SCHEMBL574396 | 1.00 | KAT8 (0.59) | KAT8IGF1RALOX15PTGS2ESR1 | |
| SCHEMBL11143627 | 1.00 | KAT8 (0.59) | KAT8IGF1RALOX15PTGS2ESR1 | |
| SCHEMBL3965946 | 1.00 | KAT8 (0.59) | KAT8IGF1RALOX15PTGS2ESR1 | |
| SCHEMBL11871334 | 1.00 | KAT8 (0.59) | KAT8IGF1RALOX15PTGS2ESR1 | |
| SCHEMBL573937 | 0.98 | IGF1R (0.61) | KAT8IGF1RALOX15PTGS2ESR1 | |
| Formaldehyde SCHEMBL11415494 | 0.95 | KAT8 (0.59) | KAT8IGF1RALOX15PTGS2ESR1 | |
| SCHEMBL574235 | 0.93 | IGF1R (0.58) | KAT8IGF1RALOX15ALDH1A1PPARA | |
| SCHEMBL10961370 | 0.91 | IGF1R (0.69) | KAT8IGF1RALOX15CYP3A4HSD17B10 | |
| Chloroxylenol SCHEMBL8780115 | 0.88 | KAT8 (0.49) | KAT8IGF1RALOX15PTGS2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| WO-2012170841-A1 | AN AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2012-12-13 | — | — | WO | claimed |
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| US-20090214606-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS CORP. | 2009-08-27 | — | — | US | claimed |
| EP-1549731-B1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2008-12-17 | — | — | EP | claimed |
| EP-1879457-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | Ciba Specialty Chemicals Holding, Inc. (CH) | 2008-01-23 | — | — | EP | claimed |
| US-20070231295-A1 | Antimicrobial Silicon Oxide Flakes | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-04 | — | — | US | claimed |
| CN-1953658-A | Antimicrobial silicon oxide flakes | CIBA SC HOLDING AG (CH) | 2007-04-25 | — | — | CN | claimed |
| WO-2005107456-A2 | ANTIMICROBIAL SILICON OXIDE FLAKES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-11-17 | — | — | WO | claimed |
| US-20050233930-A1 | Disinfectant cleaning compositions | RECKITT BENCKISER INC. (US) | 2005-10-20 | — | — | US | claimed |
| EP-1549730-A1 | DISINFECTANT CLEANING COMPOSITIONS | Reckitt Benckiser Inc. (US) | 2005-07-06 | — | — | EP | claimed |
| EP-1549731-A1 | CLEANING AND DISINFECTING COMPOSITION | Reckitt Benckiser Inc. (US) | 2005-07-06 | — | — | EP | claimed |
| EP-1537201-A1 | HARD SURFACE TREATING COMPOSITIONS | Reckitt Benckiser Inc. (US) | 2005-06-08 | — | — | EP | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| WO-2004035724-A1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2004035723-A1 | DISINFECTANT CLEANING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2004024861-A1 | HARD SURFACE TREATING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-03-25 | — | — | WO | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | KAT8 1257/4885IGF1R 3408/4885ALOX15 903/4885 |
| US-20070231295-A1 | Antimicrobial Silicon Oxide Flakes | SIK2, SIK3, SIK1 | KAT8 3208/4885IGF1R 2969/4885ALOX15 527/4885 |
| US-20090214606-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | ORAI3, PRF1, THPO | KAT8 3349/4885IGF1R 2497/4885ALOX15 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.